2-166284571-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001365536.1(SCN9A):c.1856A>C(p.His619Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000137 in 1,461,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN9A | NM_001365536.1 | c.1856A>C | p.His619Pro | missense_variant | Exon 12 of 27 | ENST00000642356.2 | NP_001352465.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN9A | ENST00000642356.2 | c.1856A>C | p.His619Pro | missense_variant | Exon 12 of 27 | NM_001365536.1 | ENSP00000495601.1 | |||
SCN9A | ENST00000303354.11 | c.1856A>C | p.His619Pro | missense_variant | Exon 12 of 27 | 5 | ENSP00000304748.7 | |||
SCN9A | ENST00000409672.5 | c.1856A>C | p.His619Pro | missense_variant | Exon 12 of 27 | 5 | ENSP00000386306.1 | |||
SCN9A | ENST00000645907.1 | c.1856A>C | p.His619Pro | missense_variant | Exon 12 of 27 | ENSP00000495983.1 | ||||
SCN9A | ENST00000454569.6 | c.1856A>C | p.His619Pro | missense_variant | Exon 12 of 15 | 1 | ENSP00000413212.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249188Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135168
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461840Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727216
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.H619P variant (also known as c.1856A>C), located in coding exon 11 of the SCN9A gene, results from an A to C substitution at nucleotide position 1856. The histidine at codon 619 is replaced by proline, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
This sequence change replaces histidine, which is basic and polar, with proline, which is neutral and non-polar, at codon 619 of the SCN9A protein (p.His619Pro). This variant is present in population databases (rs757910184, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with SCN9A-related conditions. ClinVar contains an entry for this variant (Variation ID: 471089). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SCN9A protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at